Published in Endoscopy on May 01, 1986
Bleeding from duodenal lymphangiectasia. Arch Dis Child (1991) 0.81
Primary intestinal lymphangiectasia diagnosed by endoscopy following the intake of a high-fat meal. Eur J Pediatr (2007) 0.80
A case of primary intestinal lymphangiectasia. Korean J Intern Med (1993) 0.75
Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet (2000) 5.31
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23
Functional gastroduodenal disorders. Gut (1999) 3.74
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol (1998) 3.44
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12
Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy (1996) 3.12
Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet (1991) 2.87
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85
Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut (1986) 2.74
Regular review: treatment of Helicobacter pylori infection. BMJ (2000) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis (1996) 2.66
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54
Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. J Clin Pathol (1993) 2.52
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37
Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26
Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21
Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18
Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology (1996) 2.17
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther (1999) 2.14
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis (1998) 2.09
Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94
14C-urea breath test in C pylori gastritis. Gut (1989) 1.89
Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol (1992) 1.88
cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct. Infect Immun (1998) 1.84
Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol (1996) 1.84
Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc (1986) 1.84
Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. Gut (1976) 1.83
Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. Gastrointest Endosc (1995) 1.82
Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol (1996) 1.80
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology (1997) 1.79
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology (1988) 1.75
Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology (1999) 1.74
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol (1995) 1.74
Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology (1989) 1.70
Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol (1996) 1.70
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol (1997) 1.69
Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology (1990) 1.67
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65
A patient with osteomalacia as single presenting symptom of gluten-sensitive enteropathy. J Intern Med (1992) 1.64
Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance. J Bacteriol (1996) 1.64
Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology (1995) 1.61
Can the age limit for endoscopy be increased in dyspepsia patients who do not have alarm symptoms? Am J Gastroenterol (1999) 1.60
Intestinal endotoxemia. Clinical significance. Gastroenterology (1988) 1.59
Benign biliary strictures. Surgery or endoscopy? Ann Surg (1993) 1.59
Loss of E-cadherin expression in early gastric cancer. Histopathology (1999) 1.59
Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg (1990) 1.58
Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.57
The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol (1998) 1.56
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis (1988) 1.52
Bile duct injury after laparoscopic cholecystectomy: the value of endoscopic retrograde cholangiopancreatography. Gut (1993) 1.52
Clogging of biliary endoprostheses: a new perspective. Gut (1990) 1.52
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology (2001) 1.51
Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51
Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut (1982) 1.51
Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut (1998) 1.50
A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. Am J Gastroenterol (2000) 1.50
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy. Gastrointest Endosc (2001) 1.49
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut (1999) 1.49
Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med (1996) 1.48
Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc (2001) 1.48
Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. Gastroenterology (1977) 1.44
Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol (1994) 1.44
Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2. Inflamm Bowel Dis (2000) 1.44
A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy (1998) 1.44
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol (1995) 1.43
Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis (1994) 1.42
Results of conservative treatment of benign esophageal strictures: a follow-up study in 100 patients. Gastroenterology (1982) 1.42
Treatment of instrumental oesophageal perforation. Gut (1984) 1.40
Suppression of Helicobacter pylori infection during intensive care stay: related to stress ulcer bleeding incidence? J Crit Care (2001) 1.40
Gastric metaplasia and Helicobacter pylori infection. Gut (1993) 1.40
[Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer]. Ned Tijdschr Geneeskd (2003) 1.39
[Barrett esophagus and Barrett carcinoma]. Ned Tijdschr Geneeskd (1997) 1.39
The urea breath test for Helicobacter pylori infection: taking the wind out of the sails of endoscopy. CMAJ (2000) 1.39
Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39
Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Aliment Pharmacol Ther (2006) 1.39